S Kleinman

Summary

Country: Canada

Publications

  1. ncbi The National Heart, Lung, and Blood Institute retrovirus epidemiology donor studies (Retrovirus Epidemiology Donor Study and Retrovirus Epidemiology Donor Study-II): twenty years of research to advance blood product safety and availability
    Steven Kleinman
    Department of Pathology, University of British Columbia, Victoria, British Columbia, Canada
    Transfus Med Rev 26:281-304, 304.e1-2. 2012
  2. ncbi The Leukocyte Antibody Prevalence Study-II (LAPS-II): a retrospective cohort study of transfusion-related acute lung injury in recipients of high-plasma-volume human leukocyte antigen antibody-positive or -negative components
    Steven H Kleinman
    Westat, Inc, Rockville, Maryland, USA
    Transfusion 51:2078-91. 2011
  3. ncbi A national survey of transfusion-related acute lung injury risk reduction policies for platelets and plasma in the United States
    Steven Kleinman
    AABB, Bethesda, Maryland, USA
    Transfusion 50:1312-21. 2010
  4. ncbi A linked donor-recipient study to evaluate parvovirus B19 transmission by blood component transfusion
    Steven H Kleinman
    Westat Inc, Rockville, MD, USA
    Blood 114:3677-83. 2009
  5. ncbi Survival after transfusion as assessed in a large multistate US cohort
    Steven Kleinman
    Kleinman Biomedical Research, 1281 Rockcrest Avenue, Victoria, British Columbia V9A 4W4, Canada
    Transfusion 44:386-90. 2004
  6. ncbi The donor notification process from the donor's perspective
    Steven Kleinman
    Westat, Rockville, Maryland, USA
    Transfusion 44:658-66. 2004
  7. ncbi The impact of discontinuation of 7-day storage of apheresis platelets (PASSPORT) on recipient safety: an illustration of the need for proper risk assessments
    Steven Kleinman
    University of British Columbia, Vancouver, British Columbia, Canada
    Transfusion 49:903-12. 2009
  8. ncbi Initiatives to improve blood donor screening
    S Kleinman
    Professor of Clinical Pathology, University of British Columbia, Vancouver, BC, Canada
    Dev Biol (Basel) 120:67-75. 2005
  9. ncbi False-positive HIV-1 test results in a low-risk screening setting of voluntary blood donation. Retrovirus Epidemiology Donor Study
    S Kleinman
    Westat Inc, Rockville, MD, USA
    JAMA 280:1080-5. 1998
  10. ncbi Comparison of demographic and donation profiles and transfusion-transmissible disease markers and risk rates in previously transfused and nontransfused blood donors
    B Wang
    Westat, Rockville, Maryland 20850, USA
    Transfusion 44:1243-51. 2004

Detail Information

Publications22

  1. ncbi The National Heart, Lung, and Blood Institute retrovirus epidemiology donor studies (Retrovirus Epidemiology Donor Study and Retrovirus Epidemiology Donor Study-II): twenty years of research to advance blood product safety and availability
    Steven Kleinman
    Department of Pathology, University of British Columbia, Victoria, British Columbia, Canada
    Transfus Med Rev 26:281-304, 304.e1-2. 2012
    ....
  2. ncbi The Leukocyte Antibody Prevalence Study-II (LAPS-II): a retrospective cohort study of transfusion-related acute lung injury in recipients of high-plasma-volume human leukocyte antigen antibody-positive or -negative components
    Steven H Kleinman
    Westat, Inc, Rockville, Maryland, USA
    Transfusion 51:2078-91. 2011
    ..We used a multicenter retrospective cohort study design to evaluate whether human leukocyte antigen (HLA) antibody donor screening would reduce the risk of transfusion-related acute lung injury (TRALI) or possible TRALI...
  3. ncbi A national survey of transfusion-related acute lung injury risk reduction policies for platelets and plasma in the United States
    Steven Kleinman
    AABB, Bethesda, Maryland, USA
    Transfusion 50:1312-21. 2010
    ..Little information exists on the specific transfusion-related acute lung injury (TRALI) risk reduction practices used by multiple blood collecting institutions in the United States...
  4. ncbi A linked donor-recipient study to evaluate parvovirus B19 transmission by blood component transfusion
    Steven H Kleinman
    Westat Inc, Rockville, MD, USA
    Blood 114:3677-83. 2009
    ..These data do not support the need to routinely screen blood donations with a sensitive B19V DNA nucleic acid assay...
  5. ncbi Survival after transfusion as assessed in a large multistate US cohort
    Steven Kleinman
    Kleinman Biomedical Research, 1281 Rockcrest Avenue, Victoria, British Columbia V9A 4W4, Canada
    Transfusion 44:386-90. 2004
    ..The only survival and mortality data on a general population of transfused patients in the United States is more than two decades old. More contemporary data are needed to reflect more current patient populations and transfusion practices...
  6. ncbi The donor notification process from the donor's perspective
    Steven Kleinman
    Westat, Rockville, Maryland, USA
    Transfusion 44:658-66. 2004
    ..Despite large numbers of blood donors being notified of abnormal infectious disease screening results, there has been little scientific study of the effects of this process...
  7. ncbi The impact of discontinuation of 7-day storage of apheresis platelets (PASSPORT) on recipient safety: an illustration of the need for proper risk assessments
    Steven Kleinman
    University of British Columbia, Vancouver, British Columbia, Canada
    Transfusion 49:903-12. 2009
    ..The impact of this discontinuation on recipient safety was explored using mathematical modeling...
  8. ncbi Initiatives to improve blood donor screening
    S Kleinman
    Professor of Clinical Pathology, University of British Columbia, Vancouver, BC, Canada
    Dev Biol (Basel) 120:67-75. 2005
  9. ncbi False-positive HIV-1 test results in a low-risk screening setting of voluntary blood donation. Retrovirus Epidemiology Donor Study
    S Kleinman
    Westat Inc, Rockville, MD, USA
    JAMA 280:1080-5. 1998
    ..Persons at risk of human immunodeficiency virus 1 (HIV-1) infection, have been classified incorrectly as HIV infected because of Western blot results, but the frequency of false-positive Western blot results is unknown...
  10. ncbi Comparison of demographic and donation profiles and transfusion-transmissible disease markers and risk rates in previously transfused and nontransfused blood donors
    B Wang
    Westat, Rockville, Maryland 20850, USA
    Transfusion 44:1243-51. 2004
    ..Little is known, however, about the impact of indefinite deferral of transfused donors on blood safety and availability in the US...
  11. ncbi Hepatitis G virus biology, epidemiology, and clinical manifestations: Implications for blood safety
    S Kleinman
    University of British Columbia, Vancouver, British Columbia, Canada
    Transfus Med Rev 15:201-12. 2001
    ..Because the data do not indicate any pathologic effects of HGV, it is not appropriate to screen the blood supply for HGV RNA...
  12. ncbi Does prevalence of transfusion-transmissible viral infection reflect corresponding incidence in United States blood donors?
    Baoguang Wang
    Westat, Rockville, Maryland 20850, USA
    Transfusion 45:1089-96. 2005
    ..Prevalence, however, is readily available. Understanding whether prevalence reflects corresponding incidence may help blood centers monitor disease risks...
  13. ncbi Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors
    Michael P Busch
    Blood Systems Research Institute, San Francisco, California 94118, USA
    Transfusion 46:469-75. 2006
    ..Factors associated with resolution of viremia are not well defined. Implementation of routine nucleic acid testing (NAT) of blood donors has yielded a large data set for analysis of demographic correlates of resolved viremia...
  14. ncbi A perspective on transfusion-related acute lung injury two years after the Canadian Consensus Conference
    Steven Kleinman
    Transfusion 46:1465-8. 2006
  15. ncbi Promoting recognition and prevention of transfusion-related acute lung injury
    Steven Kleinman
    AABB (American Association of Blood Banks, Bethesda, MD 20814-2749, USA
    Crit Care Nurse 27:49-53. 2007
  16. ncbi The development of West Nile virus safety policies by Canadian blood services: guiding principles and a comparison between Canada and the United States
    Eleftherios C Vamvakas
    Canadian Blood Services; Department of Pathology and Laboratory Medicine, University of Ottawa Faculty of Medicine, ON, Canada
    Transfus Med Rev 20:97-109. 2006
    ..This review discusses the guiding principles affecting CBS policy development and compares CBS WNV safety policies to policies adopted in the United States...
  17. ncbi Performance characteristics of the Food and Drug Administration-licensed Roche Cobas TaqScreen West Nile virus assay
    Anuradha Pai
    From Roche Molecular Systems, Pleasanton, California 94588, USA
    Transfusion 48:2184-9. 2008
    ..A series of studies established the performance characteristics of the assay and test system before FDA licensure...
  18. ncbi Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel
    Steven Kleinman
    Kleinman Biomedical Research, Victoria, British Columbia, Canada
    Transfusion 44:1774-89. 2004
  19. ncbi Transfusion transmission of West Nile virus: a merging of historical and contemporary perspectives
    F Blaine Hollinger
    Baylor College of Medicine, Houston, Texas, USA
    Transfusion 43:992-7. 2003
  20. ncbi Research, monitoring, and policy issues related to emerging pathogens
    Steven Kleinman
    U. British Columbia, Vancouver, BC, Canada
    Vox Sang 83:351-4. 2002
  21. ncbi The 2003 West Nile virus United States epidemic: the America's Blood Centers experience
    Steven Kleinman
    Westat, Rockville, Maryland, USA
    Transfusion 45:469-79. 2005
    ..This study demonstrates that a national collaborative effort facilitates timely surveillance of blood donor infectious disease prevalence rates...
  22. ncbi AABB survey of transfusion-related acute lung injury policies and practices in the United States
    Patricia Kopko
    Histocompatibility Laboratory, BloodSource, Sacramento, California, USA
    Transfusion 47:1679-85. 2007
    ..Policies and practices with regard to transfusion-related acute lung injury (TRALI) diagnosis, laboratory investigation of TRALI cases, and donor deferral and donor management are not standardized...